Home › Funds › SATOVSKY ASSET MANAGEMENT LLC › DRTS

SATOVSKY ASSET MANAGEMENT LLC position in DRTS

ALPHA TAU MEDICAL LTD · Health Care

SATOVSKY ASSET MANAGEMENT LLC reported holding 36,636 shares of DRTS (ALPHA TAU MEDICAL LTD) in its Q2 2026 13F filing — a position valued at US$461K, representing 0.07% of its reported portfolio and ranking #39 among its reported holdings. SATOVSKY ASSET MANAGEMENT LLC has disclosed DRTS holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)36.64K sh
Reported value held$460.88K
Portfolio Weight0.07%
First reportedQ4 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SATOVSKY ASSET MANAGEMENT LLC's DRTS position evolved

SATOVSKY ASSET MANAGEMENT LLC first disclosed a stake in DRTS in Q4 2023 at 58,430 shares (US$176K). The position peaked in Q2 2026 at 36,636 shares, worth US$461K. Across 11 filings, SATOVSKY ASSET MANAGEMENT LLC increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 36,636 shares valued at US$461K — a reduction of -4,070 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2023 58.43K $175.87K New
Q1 2024 48.59K $143.35K Reduce
Q2 2024 53.61K $135.62K Add
Q3 2024 53.61K $127.58K Hold
Q4 2024 53.61K $166.18K Hold
Q1 2025 53.61K $134.55K Hold
Q2 2025 53.61K $167.25K Hold
Q3 2025 53.61K $241.76K Hold
Q4 2025 53.61K $265.35K Hold
Q1 2026 40.71K $287.79K Reduce
Q2 2026 36.64K $460.88K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DRTS and 13F data

DRTS (ALPHA TAU MEDICAL LTD) is a Health Care company. 62 other funds we track also report a position in DRTS — the largest reported positions include Gem Investment Advisors, LLC (US$18.0M), Aquamarine Financial (Cayman) Ltd (US$9.1M), Pier Capital, LLC (US$8.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DRTS

All DRTS fund holders →

FAQ

How long has SATOVSKY ASSET MANAGEMENT LLC held DRTS?

SATOVSKY ASSET MANAGEMENT LLC has disclosed DRTS holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is SATOVSKY ASSET MANAGEMENT LLC's current position in DRTS?

As of Q2 2026, SATOVSKY ASSET MANAGEMENT LLC holds 36.64K shares of DRTS (ALPHA TAU MEDICAL LTD), valued at $460.88K, representing 0.07% of its reported portfolio and ranking #39.

Has SATOVSKY ASSET MANAGEMENT LLC been buying or selling DRTS?

In the latest 13F filing (Q2 2026), SATOVSKY ASSET MANAGEMENT LLC reduced its position in DRTS. The position peaked in Q2 2026 at 36.64K shares.

Which other funds hold DRTS?

Other major institutional holders of DRTS include Gem Investment Advisors, LLC, Aquamarine Financial (Cayman) Ltd, Pier Capital, LLC, among 62 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.